Literature DB >> 11866688

Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis.

Rafet Gazvani1, Allan Templeton.   

Abstract

Endometriosis, defined by the presence of viable endometrial tissue outside the uterine cavity, is a common condition affecting 2-3% of women of reproductive age. Today, a composite theory of retrograde menstruation with implantation of endometrial fragments in conjunction with peritoneal factors to stimulate cell growth is the most widely accepted explanation. There is substantial evidence that immunological factors and angiogenesis play a decisive role in the pathogenesis of endometriosis. In women with endometriosis, there appears to be an alteration in the function of peritoneal macrophages, natural killer cells and lymphocytes. Furthermore, growth factors and inflammatory mediators in the peritoneal fluid, produced mainly by peritoneal macrophages, are altered in endometriosis, indicating a role for these immune cells and mediators in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866688     DOI: 10.1530/rep.0.1230217

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  71 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  Antioxidant supplementation reduces endometriosis-related pelvic pain in humans.

Authors:  Nalini Santanam; Nino Kavtaradze; Ana Murphy; Celia Dominguez; Sampath Parthasarathy
Journal:  Transl Res       Date:  2012-05-31       Impact factor: 7.012

3.  Inflammatory cytokines differentially up-regulate human endometrial haptoglobin production in women with endometriosis.

Authors:  K L Sharpe-Timms; H Nabli; R L Zimmer; J A Birt; J W Davis
Journal:  Hum Reprod       Date:  2010-02-22       Impact factor: 6.918

4.  Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1alpha.

Authors:  Meng-Hsing Wu; Ko-Fan Chen; Shih-Chieh Lin; Chun-Wun Lgu; Shaw-Jenq Tsai
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 5.  Pharmacological treatment of endometriosis: experience with aromatase inhibitors.

Authors:  Simone Ferrero; Pier L Venturini; Nicola Ragni; Giovanni Camerini; Valentino Remorgida
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 6.  Endometriosis and Chronic Pelvic Pain: Unraveling the Mystery Behind this Complex Condition.

Authors:  Terri Bloski; Roger Pierson
Journal:  Nurs Womens Health       Date:  2008-10

Review 7.  Novel therapies targeting endometriosis.

Authors:  Hugh S Taylor; Kevin G Osteen; Kaylon L Bruner-Tran; Charles J Lockwood; Graciela Krikun; Anna Sokalska; Antoni J Duleba
Journal:  Reprod Sci       Date:  2011-06-21       Impact factor: 3.060

8.  Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature.

Authors:  Kasra Khalaj; Jessica E Miller; Harshavardhan Lingegowda; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  JCI Insight       Date:  2019-09-19

9.  Deficiency of immunophilin FKBP52 promotes endometriosis.

Authors:  Yasushi Hirota; Susanne Tranguch; Takiko Daikoku; Akiko Hasegawa; Yutaka Osuga; Yuji Taketani; Sudhansu K Dey
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

10.  IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors.

Authors:  Soo Hyun Ahn; Andrew K Edwards; Sukhbir S Singh; Steven L Young; Bruce A Lessey; Chandrakant Tayade
Journal:  J Immunol       Date:  2015-08-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.